Atlantic salmon found to decrease cardiovascular risk
05/27/2019 // Michelle Simmons // Views

A study published in the journal Nutrition Research examined the effect of salmon intake on lipoprotein particle size and concentration associated with cardiovascular disease risk. The study was carried out by researchers at Grand Forks Human Nutrition Research Center, the University of Minnesota, and the University of North Dakota.

  • The U.S. Dietary Guidelines for Americans suggest eating fish at least twice a week.
  • Salmon is a good source of omega-3 fatty acids which have positive lipid modifying effects, but it is unknown whether these effects are dose-dependent.
  • The researchers hypothesized that low-density lipoprotein (LDL) particle size and high-density lipoprotein (HDL) particle size and concentration would increase with salmon intake in a dose-dependent manner.
  • To test this hypothesis, they enrolled 19 overweight adults in a cross-over designed clinical trial evaluating the intake of salmon.
  • The participants were assigned to consume 90, 180, or 270 grams (g) of Atlantic salmon twice a week for four weeks.
  • Following a four- to eight-week washout, participants crossed over to another dose of fish intake until all treatments were completed.
  • The researchers found that consumption of salmon reduced plasma and serum triglyceride levels and increased plasma HDL cholesterol levels.
  • Salmon consumption also reduced very low-density lipoprotein (VLDL) particle and chylomicron particle, while LDL particle concentrations were increased in a dose-dependent manner.
  • The mean size of VLDL particle was reduced and that of LDL was increased.
  • Total triglyceride was reduced as was the triglyceride content of VLDL particle and chylomicron particle.

Overall, the findings suggested that consuming salmon twice every week affects lipoprotein particle size and concentration in a manner associated with cardiovascular disease risk reduction.

To read more studies on salmon's health benefits, visit FoodIsMedicine.com.

Journal Reference:

Raatz SK, Johnson LK, Rosenberger TA, Picklo MJ. TWICE WEEKLY INTAKE OF FARMED ATLANTIC SALMON (SALMO SALAR) POSITIVELY INFLUENCES LIPOPROTEIN CONCENTRATION AND PARTICLE SIZE IN OVERWEIGHT MEN AND WOMEN. Nutrition Research. September 2016; 36(9): 899-906. DOI: 10.1016/j.nutres.2016.06.011



Take Action:
Support Natural News by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NaturalNews.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
App Store
Android App
eTrust Pro Certified

This site is part of the Natural News Network © 2022 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
Natural News uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.